NYSE:MEDPersonal Products
Medifast (MED) Stock Rally Leans On Cash As Coach Base Shrinks
Medifast shares ripped 34% higher to about US$13.08, even though the latest quarter still showed losses and shrinking scale. Traders focused on the relief that revenue held around US$76.4 million and that losses stayed in the single digit millions. The real story sits on a longer timeline. Management is betting that a 10 year metabolic health pivot, backed by a debt free balance sheet with almost US$170 million in cash and investments, can eventually turn these lean quarters into something...